Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Amneal Pharmaceuticals, Inc.
Business Segments
Business Segments
Deferred income and reimbursable research and development services
Deferred income and reimbursable research and development services
Amneal Pharmaceuticals, Inc.
·
Business Segments
·
1 segment
Breakdown
Segments
Affordable Medicines
View metric
Annual
Segment
FY'25
Affordable Medicines
$4.1M
Total
$4.1M
All segment values are derived from annual filings.